Application Detail
Description of Medical Service
Testing for EGFR gene mutation in patients with locally advanced or metastatic NSCLC.Description of Medical Condition
Lung cancer is the second leading cause of premature death for all Australians and is the fifth most commonly diagnosed cancer in Australia. NSCLC cancer accounts for over 80% of all lung cancer cases, and is usually diagnosed at an advanced stage when surgical resection may no longer be amenable.Reason for Application
Amendment to MBS itemMedical Service Type
InvestigativePrevious Application Number
Not ApplicableAssociated Documentation
Application Form
Application Form (Word 188 KB)Application Form (PDF 830 KB)
Consultation Survey
Consultation Survey (Word 508 KB)Consultation Survey (PDF 305 KB)
PICO Confirmation
-Assessment Report
-Public Summary Document
Public Summary Document (Word 69 KB)Public Summary Document (PDF 710 KB)